ELAN
Price
$22.61
Change
+$0.16 (+0.71%)
Updated
Sep 29, 04:59 PM (EDT)
Capitalization
11.22B
38 days until earnings call
Intraday BUY SELL Signals
SUPN
Price
$43.97
Change
-$0.63 (-1.41%)
Updated
Sep 29 closing price
Capitalization
2.6B
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELAN vs SUPN

ELAN vs SUPN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ELAN vs. SUPN commentary
Sep 30, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Buy and SUPN is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ELAN vs SUPN: Fundamental Ratings
ELAN
SUPN
OUTLOOK RATING
1..100
5360
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
10048
SMR RATING
1..100
9294
PRICE GROWTH RATING
1..100
5971
P/E GROWTH RATING
1..100
199
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SUPN's Valuation (69) in the Pharmaceuticals Other industry is in the same range as ELAN (92) in the Agricultural Commodities Or Milling industry. This means that SUPN’s stock grew similarly to ELAN’s over the last 12 months.

SUPN's Profit vs Risk Rating (48) in the Pharmaceuticals Other industry is somewhat better than the same rating for ELAN (100) in the Agricultural Commodities Or Milling industry. This means that SUPN’s stock grew somewhat faster than ELAN’s over the last 12 months.

ELAN's SMR Rating (92) in the Agricultural Commodities Or Milling industry is in the same range as SUPN (94) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to SUPN’s over the last 12 months.

ELAN's Price Growth Rating (59) in the Agricultural Commodities Or Milling industry is in the same range as SUPN (71) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to SUPN’s over the last 12 months.

ELAN's P/E Growth Rating (1) in the Agricultural Commodities Or Milling industry is significantly better than the same rating for SUPN (99) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew significantly faster than SUPN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANSUPN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 8 days ago
67%
Bullish Trend 8 days ago
73%
Declines
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 5 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
68%
COMPARISON
Comparison
Sep 30, 2026
Stock price -- (ELAN: $22.45 vs. SUPN: $44.60)
Brand notoriety: ELAN: Notable vs. SUPN: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ELAN: 83% vs. SUPN: 70%
Market capitalization -- ELAN: $11.22B vs. SUPN: $2.6B
ELAN [@Pharmaceuticals: Generic] is valued at $11.22B. SUPN’s [@Pharmaceuticals: Generic] market capitalization is $2.6B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 1 FA rating(s) are green while SUPN’s FA Score has 0 green FA rating(s).

  • ELAN’s FA Score: 1 green, 4 red.
  • SUPN’s FA Score: 0 green, 5 red.
According to our system of comparison, ELAN is a better buy in the long-term than SUPN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 3 TA indicator(s) are bullish while SUPN’s TA Score has 4 bullish TA indicator(s).

  • ELAN’s TA Score: 3 bullish, 5 bearish.
  • SUPN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ELAN and SUPN are a bad buy in the short-term.

Price Growth

ELAN (@Pharmaceuticals: Generic) experienced а +0.09% price change this week, while SUPN (@Pharmaceuticals: Generic) price change was +4.25% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.30%. For the same industry, the average monthly price growth was -3.28%, and the average quarterly price growth was +37.01%.

Reported Earning Dates

ELAN is expected to report earnings on Nov 06, 2026.

SUPN is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.30% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
ELAN
Daily Signal:
Gain/Loss:
SUPN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DTD94.09-0.10
-0.11%
WisdomTree U.S. Total Dividend Fund (DTD)
KMAR31.73-0.10
-0.32%
Innovator U.S. Small Cap Power Buffer ETF - March (KMAR)
RGLO33.39-0.20
-0.58%
Russell Investments Global Equity ETF (RGLO)
SAWG24.57-0.17
-0.68%
AAM Sawgrass US Large Cap Quality Growth ETF (SAWG)
NMT10.23-0.14
-1.35%
Nuveen Massachusetts Quality Municipal Income Fund

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with PAHC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
+0.63%
PAHC - ELAN
51%
Loosely correlated
+3.63%
ZTS - ELAN
44%
Loosely correlated
+0.53%
SNDL - ELAN
39%
Loosely correlated
-0.71%
PRGO - ELAN
37%
Loosely correlated
-2.08%
SUPN - ELAN
34%
Loosely correlated
+4.55%
More

SUPN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SUPN has been loosely correlated with PRGO. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SUPN jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUPN
1D Price
Change %
SUPN100%
-1.41%
PRGO - SUPN
48%
Loosely correlated
-0.66%
INDV - SUPN
35%
Loosely correlated
-0.79%
ELAN - SUPN
33%
Loosely correlated
+0.71%
ANIP - SUPN
33%
Poorly correlated
-2.95%
EVO - SUPN
30%
Poorly correlated
+3.14%
More